BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Gene Weaver Secures Gates Foundation Grant to Advance Next-Gen Gene Insertion Platform for Affordable Therapeutics

Gene Weaver Ltd (Gene Weaver), a biology technology innovator, has received $515,214 from the Gates Foundation to support the development of a n...

May 29, 2025 | News

UniXell Biotech Initiates China’s First iPSC-Based Cell Therapy Trial for Parkinson’s Disease

Shanghai UniXell Biotechnology Co., Ltd. (UniXell Biotech), a biotech company dedicated to innovative cell therapies, announced the successful first admini...

May 26, 2025 | News

Porton Advanced and TongEYE Partner to Accelerate iPSC-Derived Cell Therapy for Blinding Eye Diseases

Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleas...

May 23, 2025 | News

KFSHRC and Cellenkos Join Forces to Launch First Saudi-U.S. Clinical Trials for Treg Cell Therapies

KFSHRC to lead Clinical Trials Targeting Aplastic Anemia and Graft vs. Host Disease Cellenkos to Support Local Cell and Gene Therapy Manufacturing at&nb...

May 23, 2025 | News

Waters Corporation Acquires Halo Labs to Advance Analytical Capabilities for Cell and Gene Therapy Development

Waters Corporation announced that it has acquired Halo Labs™, an innovator of specialized imaging technologies to detect, identify, and count i...

May 22, 2025 | News

AGC Biologics Partners with Quell Therapeutics to Advance Treg Cell Therapies for Immune Disorders

-AGC Biologics, your friendly CDMO expert, announced a partnership with Quell Therapeutics (“Quell”), a clinical-stage bio...

May 19, 2025 | News

Thermo Fisher Scientific Opens Cell and Gene Therapy Vision Center in South Korea

— Thermo Fisher Scientific, the world leader in serving science, has announced the official opening of its new Cell and Gene Therapy (CGT) Vision Cen...

May 15, 2025 | News

IASO Bio’s BCMA CAR-T Therapy Equecabtagene Autoleucel Granted Orphan Drug Designation in Saudi Arabia

IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovat...

May 12, 2025 | News

Altaris Unites WuXi and Minaris Assets to Launch Minaris Advanced Therapies as Global Cell Therapy CDMO Powerhouse

Through strategic acquisitions made by New York–based investment firm Altaris, Minaris Regenerative Medicine and the U.S. and U.K. operations of WuXi...

May 08, 2025 | News

Andelyn Biosciences Supports Nationwide Children's Novel AML Therapy with AAV Manufacturing

Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has manufac...

May 08, 2025 | News

India to Gain Faster, Affordable Access to CAR T Therapy as NKure Therapeutics Partners with CRISPR Therapeutics

CTX112™ is an off-the-shelf investigational therapy, offering the potential for faster patient access compared to current CAR T treatments....

May 08, 2025 | News

TAE Life Sciences and Ohio State Forge Landmark BNCT Partnership to Advance Next-Generation Boron-Based Cancer Therapies

TAE Life Sciences (TLS) announced the signing of a Letter of Intent to collaborate with The Ohio State University Comprehensive Cancer Center – ...

May 05, 2025 | News

RoosterBio and Thermo Fisher Partner to Accelerate Cell and Exosome Therapy Development

RoosterBio, Inc., a leading supplier of adult human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and bioprocess development services,&n...

April 30, 2025 | News

Onward Therapeutics Receives EMA Green Light for Phase 1 Trial of Allogeneic NK Cell Therapy in Relapsed DLBCL

Onward Therapeutics SA, a biotechnology company dedicated to advancing innovative cancer immunotherapies, announced that its subsidiary, Emercell SAS, has ...

April 23, 2025 | News

Stay Connected